# Fennec Pharmaceuticals Inc.: Form DEF 14A, filed Apr 25, 2025

- Company: [Fennec Pharmaceuticals Inc.](/companies/fenc.md) (CIK 1211583)
- Form: DEF 14A
- Filed: 2025-04-25
- Accepted by EDGAR: Apr 25, 2025, 16:25 ET
- Period: 2025-06-03
- Accession: 0001558370-25-005563
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1211583/000155837025005563/fencf-20250603xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1211583/000155837025005563/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1211583/000155837025005563/fencf-20250603xdef14a.htm

Filed Apr 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-005563. Last ingested by Listed: Nov 2, 2026, 19:14 ET. No prices; not investment advice.